Detailed Instructions: In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.
See one example below:
Problem: SECTION 1. LIABILITY OF BUSINESS ENTITIES PROVIDING USE OF FACILITIES
TO NONPROFIT ORGANIZATIONS.

(a) Definitions.--In this section:
(1) Business entity.--The term ''business entity'' means a
firm, corporation, association, partnership, consortium, joint
venture, or other form of enterprise.
(2) Facility.--The term ''facility'' means any real
property, including any building, improvement, or appurtenance.
(3) Gross negligence.--The term ''gross negligence'' means
voluntary and conscious conduct by a person with knowledge (at
the time of the conduct) that the conduct is likely to be
harmful to the health or well-being of another person.
(4) Intentional misconduct.--The term ''intentional
misconduct'' means conduct by a person with knowledge (at the
time of the conduct) that the conduct is harmful to the health
or well-being of another person.
(5) Nonprofit organization.--The term ''nonprofit
organization'' means--
(A) any organization described in section 501(c)(3)
of the Internal Revenue Code of 1986 and exempt from
tax under section 501(a) of such Code; or
(B) any not-for-profit organization organized and
conducted for public benefit and operated primarily for
charitable, civic, educational, religious, welfare, or
health purposes.
(6) State.--The term ''State'' means each of the several
States, the District of Columbia, the Commonwealth of Puerto
Rico, the Virgin Islands, Guam, American Samoa, the Northern
Mariana Islands, any other territory or possession of the
United States, or any political subdivision of any such State,
territory, or possession.
(b) Limitation on Liability.--
(1) In general.--Subject to subsection (c), a business
entity shall not be subject to civil liability relating to any
injury or death occurring at a facility of the business entity
in connection with a use of such facility by a nonprofit
organization if--
(A) the use occurs outside of the scope of business
of the business entity;
(B) such injury or death occurs during a period
that such facility is used by the nonprofit
organization; and
(C) the business entity authorized the use of such
facility by the nonprofit organization.
(2) Application.--This subsection shall apply--
(A) with respect to civil liability under Federal
and State law; and
(B) regardless of whether a nonprofit organization
pays for the use of a facility.
(c) Exception for Liability.--Subsection (b) shall not apply to an
injury or death that results from an act or omission of a business
entity that constitutes gross negligence or intentional misconduct,
including any misconduct that--
(1) constitutes a crime of violence (as that term is
defined in section 16 of title 18, United States Code) or act
of international terrorism (as that term is defined in section
2331 of title 18) for which the defendant has been convicted in
any court;
(2) constitutes a hate crime (as that term is used in the
Hate Crime Statistics Act (28 U.S.C. 534 note));
(3) involves a sexual offense, as defined by applicable
State law, for which the defendant has been convicted in any
court; or
(4) involves misconduct for which the defendant has been
found to have violated a Federal or State civil rights law.
(d) Superseding Provision.--
(1) In general.--Subject to paragraph (2) and subsection
(e), this Act preempts the laws of any State to the extent that
such laws are inconsistent with this Act, except that this Act
shall not preempt any State law that provides additional
protection from liability for a business entity for an injury
or death with respect to which conditions under subparagraphs
(A) through (C) of subsection (b)(1) apply.
(2) Limitation.--Nothing in this Act shall be construed to
supersede any Federal or State health or safety law.
(e) Election of State Regarding Nonapplicability.--This Act shall
not apply to any civil action in a State court against a business
entity in which all parties are citizens of the State if such State
enacts a statute--
(1) citing the authority of this subsection;
(2) declaring the election of such State that this Act
shall not apply to such civil action in the State; and
(3) containing no other provision.
Solution: Shields a business entity from civil liability relating to any injury or death occurring at a facility of that entity in connection with a use of such facility by a nonprofit organization if: (1) the use occurs outside the scope of business of the business entity; (2) such injury or death occurs during a period that such facility is used by such organization; and (3) the business entity authorized the use of such facility by the organization.
Makes this Act inapplicable to an injury or death that results from an act or omission of a business entity that constitutes gross negligence or intentional misconduct, including misconduct that: (1) constitutes a hate crime or a crime of violence or act of international terrorism for which the defendant has been convicted in any court; or (2) involves a sexual offense for which the defendant has been convicted in any court or misconduct for which the defendant has been found to have violated a Federal or State civil rights law.
Preempts State laws to the extent that such laws are inconsistent with this Act, except State law that provides additional protection from liability. Specifies that this Act shall not be construed to supersede any Federal or State health or safety law.
Makes this Act inapplicable to any civil action in a State court against a business entity in which all parties are citizens of the State if such State, citing this Act's authority and containing no other provision, enacts a statute declaring the State's election that this Act shall not apply to such action in the State.
Explanation: This Bill focuses on shielding business entities from civil liability relating to an injury or death depending on the conditions of injury, hence the generated summary is correct.

Problem: SECTION 1. SHORT TITLE.

This Act may be cited as the ''Affordability Is Access Act''.

SEC. 2. PURPOSE.

The purpose of this Act is to ensure timely access to affordable
birth control by requiring coverage without cost-sharing for oral birth
control for routine, daily use that is approved by, or otherwise
legally marketed under regulation by, the Food and Drug Administration
for use by women without a prescription.

SEC. 3. FINDINGS.

Congress makes the following findings:
(1) Access to the full range of health benefits and
preventive services, including access to birth control, as
guaranteed under Federal law, provides all people of the United
States with the opportunity to lead healthier and more
productive lives.
(2) Birth control is a critical health care benefit and
service for women. Almost all women use birth control at some
point in their lifetimes. The Centers for Disease Control and
Prevention declared it one of the Ten Great Public Health
Achievements of the 20th Century.
(3) Birth control prevents and reduces unintended
pregnancies and provides many health and socioeconomic benefits
for women. Women with access to birth control are more likely
to have higher educational and career achievement, and to earn
higher wages.
(4) Affordability and timely access have long been barriers
for women being able to use birth control. Many women struggle
to obtain the birth control they need because of cost or other
access barriers, which has contributed to the high unintended
pregnancy rate in the United States. A national survey found
that 1 in 3 women have struggled to afford birth control at
some point in their lives, and as a result, have used birth
control inconsistently. The rate is even higher for young women
who are most likely to experience an unintended pregnancy.
(5) Three separate studies have found that lack of health
coverage is significantly associated with reduced use of
prescription contraceptive methods, including birth control.
(6) The Patient Protection and Affordable Care Act (Public
Law 111-148) sought to remove barriers to care and improve
access by requiring all new health plans to cover recommended
preventive services without cost-sharing, which include women's
preventive services, including all contraceptive methods,
including birth control and sterilization for women approved by
the Food and Drug Administration and related education and
counseling.
(7) The Patient Protection and Affordable Care Act women's
preventive services benefit has significantly improved women's
access to birth control, including oral birth control for
routine, daily use. The Department of Health and Human Services
has reported that, as of 2014, more than 55,000,000 women are
benefitting from coverage without cost-sharing for women's
preventive services, including birth control, under the Patient
Protection and Affordable Care Act. Women have saved more than
$483,000,000 in out-of-pocket costs for birth control with no
copayments in 2012 compared to 2013, an average savings of $269
per woman.
(8) The most appropriate method of birth control varies
according to each individual woman's needs, medical history,
and stage of life. For instance, women may have medical
contraindications that limit their ability to use certain birth
control methods. It is critical that the full range of birth
control methods approved by the Food and Drug Administration
are available and covered without cost-sharing in order to
ensure that each woman has access to the birth control method
that best meets her needs.
(9) The determination as to whether a drug should be
available for use without a prescription is appropriately and
solely made by the Food and Drug Administration. To ensure the
safety and efficacy of a drug, including a drug available for
over-the-counter use, the appropriate scientific and medical
personnel at the Food and Drug Administration, often with input
from independent advisory panels of experts, review clinical
and other data relating to the safety and efficacy of the drug.
This scientific and medical review can occur as part of the
Food and Drug Administration's over-the-counter drug review for
potential inclusion in a monograph as generally recognized as
safe and effective, or as part of the review of a new drug
application (or an abbreviated new drug application). As part
of these regulatory processes, the appropriate scientific and
medical personnel review clinical and other data, including
data generated in controlled clinical trials. The Food and Drug
Administration also reviews consumer studies and monitors post-
marketing safety data. All of these processes ensure that the
appropriate scientific and medical personnel make the
determination of safety, quality, and efficacy of drugs
marketed to the people of the United States.
(10) Leading women's health experts, providers, and medical
associations, including the American College of Obstetricians
and Gynecologists and the American Academy of Family
Physicians, support full insurance coverage and increased
access to oral birth control over-the-counter. In 2012, the
American College of Obstetricians and Gynecologists issued a
Committee Opinion recommending approval by the Food and Drug
Administration of certain forms of birth control for over-the-
counter use to increase timely access to birth control.
Furthermore, data demonstrates that birth control that is
available over-the-counter has public support and would
increase birth control usage and continuation. The Committee
Opinion followed similar recommendations made by leading
reproductive health experts and published in the American
Journal of Public Health.
(11) Research shows that birth control available over-the-
counter, as an addition to, not a substitute for, the women's
preventive health benefit under the Patient Protection and
Affordable Care Act, would increase accessibility for oral
birth control for routine, daily use.

SEC. 4. SENSE OF THE HOUSE OF REPRESENTATIVES.

It is the sense of the House of Representatives that--
(1) in order to increase women's access to oral birth
control, it must be both easier to obtain and affordable and,
to make it either easier to obtain or more affordable, but not
both, is to leave unacceptable barriers in place for women;
(2) it is imperative that the entities that research and
develop oral birth control and whose medical and scientific
experts have developed clinical and other evidence that oral
birth control for routine, daily use is safe and effective for
women when sold without a prescription, apply to the Food and
Drug Administration for review and approval for sale of such
birth control without a prescription;
(3) upon the receipt of such an application, the Food and
Drug Administration should determine whether the oral birth
control meets the rigorous safety, efficacy, and quality
standards for over-the-counter use under the Federal Food,
Drug, and Cosmetic Act (21 U.S.C. 301 et seq.), and if the
product meets those standards, the Food and Drug Administration
should approve the application without delay; and
(4) if and when the Food and Drug Administration approves
an oral birth control that is available over-the-counter, such
birth control should be covered by health insurance, without a
prescription and without cost-sharing.

SEC. 5. ENSURING COVERAGE OF ORAL BIRTH CONTROL FOR USE WITHOUT A
PRESCRIPTION.

Section 2713(a)(4) of the Public Health Service Act (42 U.S.C.
300gg-13(a)(4)) is amended by inserting ''(including oral
contraceptives for routine, daily use approved by the Food and Drug
Administration for use without a prescription, even if the individual
does not have a prescription for such contraceptive)'' after
''additional preventive care''.

SEC. 6. RULES OF CONSTRUCTION.

(a) Non-Interference With FDA Regulation.--Nothing in this Act (or
the amendment made by this Act) shall be construed to modify or
interfere with Food and Drug Administration processes to review or
approve, or otherwise determine the safety and efficacy of, and make
available, non-prescription drugs or devices, modify or interfere with
the scientific and medical considerations of the Food and Drug
Administration, or alter any other authority of the Food and Drug
Administration.
(b) Non-Preemption.--Nothing in this Act (or the amendment made by
this Act) preempts any provision of Federal or State law to the extent
that such Federal or State law provides protections for consumers that
are greater than the protections provided for in this Act.

SEC. 7. DUTIES OF RETAILERS TO ENSURE ACCESS TO ORAL BIRTH CONTROL FOR
USE WITHOUT A PRESCRIPTION.

(a) In General.--Any retailer that stocks oral birth control for
routine, daily use that is approved by, or otherwise legally marketed
under regulation by, the Food and Drug Administration for use without a
prescription may not interfere with an individual's access to or
purchase of such birth control or access to medically accurate,
comprehensive information about such birth control.
(b) Limitation.--Nothing in this section shall prohibit a retailer
that stocks oral birth control for routine, daily use from refusing to
provide an individual with such oral birth control that is approved by,
or otherwise legally marketed under regulation by, the Food and Drug
Administration if the individual is unable to pay for the birth
control, directly or through insurance coverage.
Solution:
Affordability Is Access Act This bill amends the Public Health Service Act to require health insurance and group health plans to cover, as preventive care for women, over-the-counter oral contraceptives for daily use, regardless of whether an enrollee has a prescription for the contraceptive. (Insurers and plans cannot impose cost sharing for preventive care.)